Copenhagen - Delayed Quote DKK

Novo Nordisk A/S (NOVO-B.CO)

270.15 -0.05 (-0.02%)

At close: 4:59:47 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

GlobeNewswire 6h ago

NVO
GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026

GlobeNewswire 1d ago

NVO

LLY

GNFT.PA
Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036

GlobeNewswire 4d ago

NVO

HLF

MDT
Novo to present new liver data across Wegovy 2.4 mg and investigational efruxifermin at The Liver Meeting® (AASLD) 2026

PR Newswire 6d ago

NVO
Orbis Medicines Appoints Joanne Smith-Farrell, Ph.D., as CEO to Advance Its AI-Driven Oral Macrocycle Platform and Pipeline

Business Wire 7d ago

NVO
Novo Nordisk A/S - share repurchase programme

GlobeNewswire 8d ago

NVO
Novo Nordisk A/S - share repurchase programme

GlobeNewswire 15d ago

NVO
Ablexis Announce License Agreement with Novo

ACCESS Newswire 20d ago

NVO
Novo Nordisk A/S - share repurchase programme

GlobeNewswire 22d ago

NVO
Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

Business Wire 26d ago

SRRK

NVO
Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight

GlobeNewswire 29d ago

NVO

LLY

1672.HK
CN Bio Announces Expert Speaker Line-Up and Scientific Program for Inaugural Organ-on-a-Chip e-Symposium

Business Wire 29d ago

NVO

BMY

Performance Overview

Return	NOVO-B.CO	OMX Copenhagen 25 Index (^OMXC25)
YTD	-12.98%	+9.12%
1-Year	-10.24%	+18.14%
3-Year	-56.96%	+20.28%

U.S. markets close in 2h 32m

Novo Nordisk A/S (NOVO-B.CO)

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026

Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036

Novo to present new liver data across Wegovy 2.4 mg and investigational efruxifermin at The Liver Meeting® (AASLD) 2026

Orbis Medicines Appoints Joanne Smith-Farrell, Ph.D., as CEO to Advance Its AI-Driven Oral Macrocycle Platform and Pipeline

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme

Ablexis Announce License Agreement with Novo

Novo Nordisk A/S - share repurchase programme

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight

CN Bio Announces Expert Speaker Line-Up and Scientific Program for Inaugural Organ-on-a-Chip e-Symposium